CWGCX
Price
$68.12
Change
+$0.24 (+0.35%)
Updated
Jun 6 closing price
Net Assets
130.86B
LGCRX
Price
$18.22
Change
+$0.05 (+0.28%)
Updated
Jun 6 closing price
Net Assets
174.84M
Interact to see
Advertisement

CWGCX vs LGCRX

Header iconCWGCX vs LGCRX Comparison
Open Charts CWGCX vs LGCRXBanner chart's image
American Funds Capital World Gr&Inc C
Price$68.12
Change+$0.24 (+0.35%)
VolumeN/A
Net Assets130.86B
Lord Abbett Global Equity R3
Price$18.22
Change+$0.05 (+0.28%)
VolumeN/A
Net Assets174.84M
CWGCX vs LGCRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CWGCX vs. LGCRX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Buy and LGCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 131B vs. LGCRX (175M). CWGCX pays higher dividends than LGCRX: CWGCX (0.87) vs LGCRX (0.15). CWGCX was incepted earlier than LGCRX: CWGCX (24 years) vs LGCRX (8 years). LGCRX (1.97) is less costly to investors than CWGCX (1.49). LGCRX is a more actively managed with annual turnover of: 41.00 vs. CWGCX (27.00). LGCRX has a lower initial minimum investment than CWGCX: LGCRX (0) vs CWGCX (250). LGCRX annual gain was more profitable for investors over the last year : 14.39 vs. CWGCX (5.53). LGCRX return over 5 years is better than : 58.55 vs. CWGCX (42.30).
CWGCXLGCRXCWGCX / LGCRX
Total Expense Ratio1.491.15130%
Annual Report Gross Expense Ratio1.491.9776%
Fund Existence24 years8 years-
Gain YTD8.7119.98887%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets131B175M74,857%
Annual Yield % from dividends0.870.15575%
Returns for 1 year5.5314.3938%
Returns for 3 years26.8648.1556%
Returns for 5 years42.3058.5572%
Returns for 10 years49.31N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV6.200.47
+8.12%
Verve Therapeutics
PIII6.620.14
+2.24%
P3 Health Partners Inc
VSAT9.210.09
+0.99%
ViaSat
NLY19.060.18
+0.95%
Annaly Capital Management
RELI1.47-0.04
-2.65%
Reliance Global Group Inc.